It has been shown that doxycycline acts as L55P TTR amyloid fibril disruptor in vitro [40] and disaggregates amyloid deposits in V30M TTR transgenic mice with a concomitant decrease of various amyloidosis tissue markers [41,42]. The gene discussed is TTR; the disease is amyloidosis.